Read the Beforeitsnews.com story here. Advertise at Before It's News here.
Profile image
Story Views
Now:
Last hour:
Last 24 hours:
Total:

We All Share Julian Assange’s Fate

% of readers think this story is Fact. Add your two cents.


Editor’s note: This article was first published in The Progressive.

The prosecution of WikiLeaks founder Julian Assange under the Espionage Act represents a dangerous turn in President Donald Trump’s war on the First Amendment. Whether you love Assange or loathe him, it is vital to understand the eighteen-count indictment filed against him on May 23 in the context of that wider conflict. In a very real sense, we are all defendants in the case against Assange.

The new charges allege that Assange collaborated with former Army Intelligence Officer Chelsea Manning from 2009 to 2011 to obtain and publish national defense information about the wars in Afghanistan and Iraq. items supplied by Manning included more than 250,000 classified State Department cables as well as several CIA-interrogation videos. Manning also leaked the now-widely viewed video of a 2007 attack staged by U.S. military Apache helicopters in Baghdad that killed two Reuters employees and a dozen other people.

The new charges supersede an earlier one-count indictment that was filed secretly under seal in March 2018 and cited Assange for conspiring with Manning to decode a Defense Department computer password. Assange is currently in a London jail, serving a fifty-week sentence for jumping bail in 2012 while facing extradition to Sweden on rape allegations. He now faces extradition to the United States as well.

That would be a horrific outcome, not only for Assange personally, but for anyone concerned with freedom of the press.

Although the prosecution of government leakers like Manning has become more common in recent decades, prosecution of a news entity for publishing leaked information is something new. As the Congressional Research Service noted in a lengthy 2017 analysis:

“While courts have held that the Espionage Act and other relevant statutes allow for convictions for leaks to the press, the government has never prosecuted a traditional news organization for its receipt [and publication] of classified or other protected information.”

Indeed, the prosecution of Assange for alleged violations of the Espionage Act reopens a threat to press freedom that hasn’t been seen in decades.

In the landmark “Pentagon Papers” case (New York Times Company v. United States), the Supreme Court quashed the Nixon Administration’s effort to enjoin the Times and The Washington Post from publishing materials disclosed to them by former military analyst Daniel Ellsberg. By a vote of 6-3, the court held that the attempt to place “prior restraints” on the two newspapers ran afoul of the First Amendment.

Similarly, in October 1979, a federal appeals court dismissed a complaint brought against The Progressive magazine on behalf of the Department of Energy to prevent publication of a feature story entitled, “The H-Bomb Secret.” The Progressive published the H-bomb article the following month. (Full disclosure: My review of G. William Domhoff’s book, “The Powers that Be: Processes of Ruling Class Domination in America,” appeared in the same issue.)

The Department of Justice, now run by Attorney General William Barr, no doubt will contend that WikiLeaks is not a legitimate news organization deserving of Constitutional protections. But in fact, Assange and WikiLeaks have been honored over the years with several international journalism awards.

In any event, it is unlikely that the Department of Justice will be able to draw a principled distinction between publishers that merit First Amendment safeguards and those who do not.

Notably, the Obama Administration declined to indict Assange because of what was then described as the “New York Times problem”—that if Assange were charged, the Times, the Post and the Guardian, among others, would also have to be prosecuted for publishing files leaked by Manning.

The Trump Administration now appears ready to evade and, if possible, eradicate the “New York Times” problem, arguing that although the Espionage Act has never been applied to a publisher in the past, there’s a first time for everything. In making that argument, the administration will be able to point to the text of the act, which prohibits both the illegal acquisition and the subsequent publication of classified material.

Nor would the Pentagon Papers or The Progressive cases preclude the prosecution of Assange, as they applied only to prior restraints on publication. Neither case held that news outlets could not be prosecuted post-publication. The Supreme Court explicitly left the question unresolved in the Pentagon Papers case.

Trump has long been fixated with the press, which he has often slandered as “the enemy of the people.” In one of his first campaign speeches on the subject, delivered in Fort Worth, Texas, in February 2016, he promised to take revenge on the media if elected, telling a cheering audience:

“I think the media is among the most dishonest groups of people I’ve ever met. They’re terrible. . . If I become President, oh, do they have problems. They’re going to have such problems.”

Driven as always by self-interest and opportunism, Trump has now flipped from professing his “love” for WikiLeaks during the campaign to targeting Assange as part of the enemy. Conveniently, and fully consistent with the President’s opportunism, the current charges lodged against Assange do not involve WikiLeaks’ publication of materials hacked from the email accounts of the Democratic National Committee—an act that clearly benefited Trump.

If Assange is sent to the United States and convicted on all counts, he could be sentenced to 175 years in federal prison. While we are still a long way from that, one thing is certain: Unless and until the prosecution of Assange is dismissed, no publication will be safe from the Trump Administration’s vengeance and overreach.


Source: https://www.truthdig.com/articles/we-all-share-julian-assanges-fate/


Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world.

Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.

"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.

Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.


LION'S MANE PRODUCT


Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules


Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.



Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.


Report abuse

    Comments

    Your Comments
    Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

    MOST RECENT
    Load more ...

    SignUp

    Login

    Newsletter

    Email this story
    Email this story

    If you really want to ban this commenter, please write down the reason:

    If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.